Homeostasis of cellular proteins is maintained through a combination of synthesis and degradation. The pathway that accounts for the majority of protein degradation is the ubiquitin-proteasomal pathway. Ubiquitin (Ub) is highly conserved in all cells and the generation of a multi-Ub chain typically targets proteins for degradation by the proteasome. However, ubiquitination is highly reversible and dynamic. Deubiquitination, the reverse process, is catalyzed through the action of enzymes referred to as isopeptidases or deubiquitinating enzymes (DUBs) [1, 2]. This group of enzymes is collectively responsible for maintaining adequate pools of free ubiquitin and regulating the ubiquitination status of cellular proteins. The class of DUBs referred to as the ubiquitin-specific proteases (USP) family functions endoproteolytically to cleave Ub chains from a wide range of protein substrates. USP2a deubiquitinates fatty acid synthase (FASN) which has recently been identified as an emerging oncology target [3-6]. To identify inhibitors of USP2a a cell-free assay was employed. This assay takes advantage of attaching an Ub or UBL (ubiquitin-like protein) to a reporter enzyme, rendering the reporter catalytically inactive. The reporter enzyme chosen is phospholipase A2 (PLA2), which has an absolute requirement for a free amino terminus. Thus, fusion of a UBL to the N-terminus of PLA2 inactivates PLA2.  When the UBL-PLA2 reporter enzyme is cleaved by USP2, the activated reporter can subsequently act on its substrate, which is the commercially available NBD C6-HPC (Invitrogen).  Thus, this coupled assay gives a fluorescent read-out, which is generated through the cleavage of the PLA2 reporter enzyme. The assay, developed by Progenra, Inc. uses Ub-PLA2 and USP2a at near equal and low (nM) amounts and has been licensed for sale by LifeSensors, Inc. as the Ub-IsoPro1 kit. The assay buffer, prepared fresh at the day of the assay, contains 20mM Tris-HCl pH 8.0, 2mM CaCl2, 2mM beta-Mercaptoethanol, 0.1% DMSO. 3ul of 40nM (20nM final) USP2 core, which is stored on ice, is dispensed into a medium-binding black solid Kalypsys 1,536 well plate using the Kalypsys dispenser. The assay plate is then pinned with 23nL compound with the Kalypsys pintool in columns 5-48. The controls are pinned as follows: column 1&2 two-fold dilutions of 2M NEM in duplicate; column 3 DMSO; column 4 2M NEM (final concentration 38.2mM). The assay plate is incubated at RT for 30min. Subsequently, 3uL of 40nM (20nM final) Ub-PLA2 and 40uM (20uM final) NBD C6-HPC (stored on ice and protected from light) were dispensed into the plate using the Kalypsys dispenser. Plates were read immediately (0 Hour) on an Envision (Perkin Elmer) plate reader using the following wavelengths Ex 460nm /Em 535nm. Then, the assay plates were incubated for 2.5 hours and read again on the Envision using the same settings Data were normalized to the to AC100 inhibition (NEM). Concentration-response curves were fitted to the normalized data and the concentration-response curves were then classified based on curve quality (r2), response magnitude and degree of measured activity. The time zero reading was used to flag fluorescence artifacts.
bao:BAO_0001067 "1455" ; # "is primary assay of" -> "1455"
bao:BAO_0001067 "2278" ; # "is primary assay of" -> "2278"
bao:BAO_0000812 "2281" ; # "has summary assay" -> "2281"
bao:BAO_0000808 bao:BAO_0000031 ; # "has primary assay" -> "primary assay"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000357 ; # "has assay format" -> "single protein format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000222 ; # "has participant" -> "generic hydrolase" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "hydrolase activity assay" ; # "is bioassay type of" -> "hydrolase activity assay"
bao:BAO_0000212 bao:BAO_0000124 ; # "has assay method" -> "enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0000142 ; # "has assay method" -> "coupled enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0002592 ; # "has assay method" -> "protease coupled enzyme activity measurement method"
bao:BAO_0000207 bao:BAO_0000363 ; # "has detection method" -> "fluorescence intensity"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Identification of inhibitors of ubiquitin-specific protease USP2a" ; # "screening campaign name" -> "Identification of inhibitors of ubiquitin-specific protease USP2a"
bao:BAO_0002853 "qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a" ; # "has assay title" -> "qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a"
bao:BAO_0000212 bao:BAO_0000139 ; # "has assay method" -> "direct enzyme activity measurement method"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000535 ; # "has concentration throughput" -> "multiple concentration"
bao:BAO_0002833 "2.5 hour" ; # "has incubation time value" -> "2.5 hour"
bao:BA0_0090012 "NEM" ; # "has participant" -> "NEM"
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Ben Nicholson" ; # "material entity assay provider" -> "Ben Nicholson" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0000694 ; # "has participant" -> "Tris" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BAO_0002739 "Ubiquitin-like protein-phospholipase A2" ; # "has substrate" -> "Ubiquitin-like protein-phospholipase A2" || bao:BAO_0003102 bao:BAO_0002030 ; # "has role" -> "coupled substrate"
bao:BA0_0090012 bao:BAO_0000972 ; # "has participant" -> "NBD C6-HPC" || bao:BAO_0003102 bao:BAO_00020143 ; # "has role" -> "substrate"
bao:BA0_0090012 "Ubiquitin carboxyl-terminal hydrolase 2" ; # "has participant" -> "Ubiquitin carboxyl-terminal hydrolase 2"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "O75604" ; # "uniprot ID" -> "O75604"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
bao:BAO_0002662 bao:BAO_0000644 ; # "has quality" -> "truncated"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000701 ; # "uses detection instrument" -> "EnVision Multilabel Reader"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "460 nanometer" ; # "has excitation wavelength value" -> "460 nanometer"
bao:BAO_0002918 "535 nanometer" ; # "has emission wavelength value" -> "535 nanometer"
bao:BAO_0000208 bao:BAO_0000186 ; # "has endpoint" -> "AC50"
bao:BAO_0000337 bao:BAO_0000656 ; # "has percent response" -> "efficacy"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "3" ; # "PubChem TID" -> "3"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002787 "38" ; # "has concentration-point number" -> "38"
bao:BAO_0002845 "2" ; # "has repetition point-number" -> "2"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie" ; # "Annotated by" -> "kunie"
